Belpointe Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,568
Closed -$65.6K 914
2023
Q1
$65.6K Sell
1,568
-990
-39% -$41.7K ﹤0.01% 1557
2022
Q4
$111K Buy
+2,558
New +$109K 0.01% 1184

Other funds holding BME

Belpointe Asset Management's BME Position: Q2 2023 in Review

Belpointe Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q2 2023, closing a stake of 1,568 shares — an estimated $65.6K sold.

Belpointe Asset Management first reported a position in BME in Q4 2022 and held it in 2 quarters. The position peaked at $111K in Q4 2022. 69 funds tracked by Wall St. Rank hold BME as of Q2 2023.

  • Belpointe Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 1,568 BlackRock Health Sciences Trust shares in Q2 2023, an estimated $65.6K.
  • Belpointe Asset Management first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's BlackRock Health Sciences Trust position peaked at $111K in Q4 2022.
  • 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.